Moin, A.; Huwaimel, B.; Alobaida, A.; Break, M.K.B.; Iqbal, D.; Unissa, R.; Jamal, Q.M.S.; Hussain, T.; Sharma, D.C.; Rizvi, S.M.D.
Dithymoquinone Analogues as Potential Candidate(s) for Neurological Manifestation Associated with COVID-19: A Therapeutic Strategy for Neuro-COVID. Life 2022, 12, 1076.
https://doi.org/10.3390/life12071076
AMA Style
Moin A, Huwaimel B, Alobaida A, Break MKB, Iqbal D, Unissa R, Jamal QMS, Hussain T, Sharma DC, Rizvi SMD.
Dithymoquinone Analogues as Potential Candidate(s) for Neurological Manifestation Associated with COVID-19: A Therapeutic Strategy for Neuro-COVID. Life. 2022; 12(7):1076.
https://doi.org/10.3390/life12071076
Chicago/Turabian Style
Moin, Afrasim, Bader Huwaimel, Ahmed Alobaida, Mohammed Khaled Bin Break, Danish Iqbal, Rahamat Unissa, Qazi Mohammad Sajid Jamal, Talib Hussain, Dinesh C. Sharma, and Syed Mohd Danish Rizvi.
2022. "Dithymoquinone Analogues as Potential Candidate(s) for Neurological Manifestation Associated with COVID-19: A Therapeutic Strategy for Neuro-COVID" Life 12, no. 7: 1076.
https://doi.org/10.3390/life12071076
APA Style
Moin, A., Huwaimel, B., Alobaida, A., Break, M. K. B., Iqbal, D., Unissa, R., Jamal, Q. M. S., Hussain, T., Sharma, D. C., & Rizvi, S. M. D.
(2022). Dithymoquinone Analogues as Potential Candidate(s) for Neurological Manifestation Associated with COVID-19: A Therapeutic Strategy for Neuro-COVID. Life, 12(7), 1076.
https://doi.org/10.3390/life12071076
